New Therapy For Relapsing-Remitting Multiple Sclerosis (RRMS) Developed by Merck Pharmaceuticals Relapsing-Remitting Multiple Sclerosis (RRMS) may have a solution thanks to a revolutionary therapy that promises to reduce outbreaks by 67%… October 30, 2018 · by Vadim Caraiman · 0